RVTY

#867
Revvity, Inc.
93.9125 USD
+2.12%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
93.6000
94.1500
Годовой диапазон
83.4800
118.2600
Дневное изменение
+2.12%
Месячное изменение
+8.61%
6-месячное изменение
-1.00%
Годовое изменение
-1.00%
Предыдущее закрытие
91.9600
Открыть
93.6000
Bid
Ask
Минимум
93.6000
High
94.1500
Объем
50
Открыть полный график

Financials

Обзор Отчетность Статистика Дивиденды
Квартал Год
  • Market Capitalization 10.4994 B
  • Employee 11 K
  • Founded N/A
  • CEO Prahlad Singh
  • Website www.revvity.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000FXW512
  • Industry Technology
Общий доход
Чистая прибыль
Базовая прибыль на акцию
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Коэффициент цена/прибыль
46.91
Коэффициент цена/денежный поток
3.96
Дивиденды на акцию
0.28
Дивидендная доходность, %
0.29

Revvity Inc

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines. In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY.

Новости